Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Bausch Health Companies Inc BHC


Primary Symbol: T.BHC

Healthcare
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:BHC)

Bausch Health to Announce First-Quarter 2024 Results on May 2

Accesswire 13 days ago

Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029

Accesswire 13 days ago

Canadian Investment Regulatory Organization Trade Resumption - BHC

Canada NewsWire 13 days ago

Canadian Investment Regulatory Organization Trading Halt - BHC

Canada NewsWire 13 days ago

Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan

Accesswire 13 days ago

Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals

Accesswire April 5, 2024

Canadian Investment Regulatory Organization Trade Resumption - BHC

Canada NewsWire April 3, 2024

Canadian Investment Regulatory Organization Trading Halt - BHC

Canada NewsWire April 3, 2024

Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults

Accesswire April 3, 2024
View More News ››

Opinion & Analysis (TSX:BHC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:BHC)

RE:BLCO spinoff

At a ratio of .85 BLCO to BHC shares, a warrant to purchase .85 of a share of BLCO at $4 usd would net BHC over 1.2b usd for debt...
borderguy - April 8, 2024

BLCO spinoff

Seem like smaller shareholders of the parent company BHC are giving away the gem of the company. During the orginal IPO of BLCO that just...
borderguy - April 8, 2024

Receive Registration Certifications in China T.BHC

Approval Represents an Important Breakthrough in One of the Largest Medical Aesthetics Markets LAVAL, QC / ACCESSWIRE / January 18...
Betteryear2 - January 18, 2024

Record Q3 revenue for CEMATRIX

Pharmaceutical companies are great investments long term but I bet many of you investors are looking for that 10 bagger. Here it is...
kingscorpion - November 8, 2023

Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)

LAVAL, QC / ACCESSWIRE / June 30, 2023 / Bausch + Lomb Corporation (NYSE/TSX:BLCO), a subsidiary of Bausch Health Companies Inc...
Betteryear2 - June 30, 2023

Massive Short Squeeze Coming on RHT. Don't miss this...

Short interest increased on Reliq Health Technologies right when the company is breaking out. 1st Quarter financial update out in a week....
SqueezePlay21 - November 21, 2022
View more Bullboard ››

Voltage Metals Corp

Voltage Metals Corp

Voltage Metals Corp. is a Canada-based critical metals exploration and development company. The Company is focused on ...
View More »